ask="2.20"
ask_size="1600"
average_daily_volume="162756"
bid="2.00"
bid_size="1000"
book_value="1.48"
change="+0.00"
change_from_200_day_moving_average="0.38"
change_from_50_day_moving_average="0.50"
change_from_52_week_high="-1.20"
change_From_52_week_low="1.05"
change_in_percent="+0.00%"
close="2.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.33"
ebitda="-17.29M"
eps_estimate_current_year="-1.10"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.54"
ex_dividend_date="N/A"
float_shares="11990000"
high="2.20"
high_52_weeks="3.35"
last_trade_date="1/31/2017"
last_trade_price="2.15"
last_trade_size="500"
last_trade_time="4:00pm"
low="2.05"
low_52_weeks="1.10"
market_capitalization="40.61M"
moving_average_200_day="1.77"
moving_average_50_day="1.65"
name="Cancer Genetics
Inc."
notes="N/A"
one_year_target_price="6.58"
open="2.15"
pe_ratio="N/A"
peg_ratio="-0.05"
percent_change_from_200_day_moving_average="+21.47%"
percent_change_from_50_day_moving_average="+30.59%"
percent_change_from_52_week_high="-35.82%"
percent_change_from_52_week_low="+95.45%"
previous_close="2.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.46"
price_per_sales="1.60"
revenue="25.30M"
shares_outstanding="18887000"
short_ratio="1.78"
stock_exchange="NCM"
symbol="CGIX"
volume="124594"
weeks_range_52="1.10 - 3.35"
